1. Identification of Prognostic Markers for LUAD based on Rank Expression of Long non-coding RNA
   Zhiqiang Chang et al, 2018, 2018 5th International Conference on Systems and Informatics (ICSAI) CrossRef
2. Clinical diagnosis of EML4–ALK mutation in NSCLC by a gold nanoparticle beacon
   Yuxi Liu et al, 2016, RSC Advances CrossRef
3. Concomitance of EGFR mutations and ALK rearrangement in patients with Lung Cancer
   Hind Berradi et al, 2018, Gene Reports CrossRef
4. Non-small cell lung cancer biomarkers and targeted therapy - two faces of the same coin fostered by nanotechnology
   Rita Mendes et al, 2016, Expert Review of Precision Medicine and Drug Development CrossRef
5. Concomitant EML4-ALK rearrangement and EGFR mutation in non-small cell lung cancer patients: a literature review of 100 cases
   Giuseppe Lo Russo et al, 2017, Oncotarget CrossRef
6. A Molecular Troika of Angiogenesis, Coagulopathy and Endothelial Dysfunction in the Pathology of Avascular Necrosis of Femoral Head: A Comprehensive Review
   Monica Singh et al, 2023, Cells CrossRef
7. Non-Canonical Thinking for Targeting ALK-Fusion Onco-Proteins in Lung Cancer
   Wei Wu et al, 2017, Cancers CrossRef